Organization: Health Canada
Year: 2022
Month: December
Request Number: A-2022-000903
Request Summary: Adverse Drug Reaction (ADR) for VYVANSE. Report number: 001004031. ADR for GAMMAGARD LIQUID. Report number: 001000322. ADRs for Immunoglobulin (human). Report numbers: E2B_05580252, E2B_05524240, E2B_05586458, E2B_05548682, E2B_05552929, E2B_05600522, 001002475. ADR for Antihemophilic factor (human). Report number: E2B_05551873.
Disposition: Disclosed in part
Number of pages: 148